These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 2563272)

  • 41. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
    Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
    J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.
    Kurata A; Palker TJ; Streilein RD; Scearce RM; Haynes BF; Berzofsky JA
    J Immunol; 1989 Sep; 143(6):2024-30. PubMed ID: 2528586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection.
    Hernández Marin M; Márquez Bocalandro Y; Vallejo RV; Rodríguez Tanty C; Higginson Clark D; Pozo Peña L; Silva León C
    Prep Biochem Biotechnol; 2003 Feb; 33(1):29-38. PubMed ID: 12693813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
    Hadlock KG; Rowe J; Perkins S; Bradshaw P; Song GY; Cheng C; Yang J; Gascon R; Halmos J; Rehman SM; McGrath MS; Foung SK
    J Virol; 1997 Aug; 71(8):5828-40. PubMed ID: 9223472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.
    Chen YM; Lee TH; Samuel KP; Okayama A; Tachibana N; Miyoshi I; Papas TS; Essex M
    J Virol; 1989 Nov; 63(11):4952-7. PubMed ID: 2677406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cross reactivity and amino acid structural homology of immunodominant peptide fragments of structural viruses from the human retroviruses HTLV-I, HTLV-II, HIV-1, and HIV-2].
    Rasuli AM; Rasuli ShM; Klepikov NN; Andreev SM; Meshcheriakova DV; Tarasova SO; Seniuta NB; Syrtsev AV; Gurtsevich VE
    Mol Biol (Mosk); 1995; 29(1):225-38. PubMed ID: 7723762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Identification of immunoreactive epitopes in proteins coded by gag, env, and pol genes of the type I human T-lymphotropic virus (HTLV-I) using synthetic peptides].
    Iaroslavtseva NG; Ivanov VS; Grebennikova ZhO; Kornilaeva GV; Pashkova TA; Chikin LD; Ostrovskiĭ AG; Andreev SM; Khaitov RM; Karamov EV
    Bioorg Khim; 1995 Oct; 21(10):752-60. PubMed ID: 8573207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
    Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
    J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of monoclonal antibody, gp21-34, against HTLV-II envelope protein (p20E).
    Miyagawa E; Yoshiki A; Fujii N; Honda H; Ueno E; Kurano Y; Ito S
    Hybridoma; 1998 Aug; 17(4):347-54. PubMed ID: 9790069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
    Hadlock KG; Rowe J; Foung SK
    J Virol; 1999 Feb; 73(2):1205-12. PubMed ID: 9882322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of HTLV-I envelope protein fused to hydrophobic amino-terminal peptide of baculovirus polyhedrin in insect cells and its application for serological assays.
    Nyunoya H; Ogura T; Kikuchi M; Iwamoto H; Yamashita K; Maekawa M; Takebe Y; Miyamura K; Yamazaki S; Shimotohno K
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1311-21. PubMed ID: 2078412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus.
    Marin MH; Rodríguez-Tanty C; Higginson-Clarke D; Bocalandro YM; Peña LP
    Biochem Biophys Res Commun; 2005 Oct; 336(3):983-6. PubMed ID: 16157308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
    Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
    J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
    Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
    J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
    Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
    Sagara Y; Inoue Y; Shiraki H; Jinno A; Hoshino H; Maeda Y
    J Virol; 1996 Mar; 70(3):1564-9. PubMed ID: 8627675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.
    Londos-Gagliardi D; Dalibart R; Geoffre S; Dalbon P; Pouliquen JF; Georges-Courbot MC; Sainte-Foie S; Hajjar C; Georges AJ; Moreau JP; Guillemain B
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):941-50. PubMed ID: 8798979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
    Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.